Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 4, 1999, Pages 1346-1350

  Støving, René Klinkby ^a   Flyvbjerg, Allan ^b   Frystyk, Jan ^b   Fisker, Sanne ^b   Hangaard, Jørgen ^a   Hansen Nord, Michael ^a   Hagen, Claus ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0033306887     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.4.1346     Document Type: Article

References (33)

1. Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nerrosa: No evidence of involvement of a low somatomedin-C level in the abnormal GH secretion
2. 2-Adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation
3. Spontaneous nocturnal growth hormone secretion in anorexia nervosa
4. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins
5. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa
6. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: Effect of short- and long-term weight recuperation
7. Blunted growth hormone responses to clonidine in adolescent girls with early anorexia nervosa. Evidence for an early hypothalamic defect
8. Growth hormone receptor and serum binding protein: Purification, cloning and expression
9. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty
10. Free insulin-like growth factors in human obesity
11. The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery
12. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness
13. Insulin-like growth factor binding protein-3 proteolysis is induced after elective surgery
14. Acquired growth hormone resistance in patients with hypercatabolism
15. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: Discrepancies between radioimmunoassay and ligand blotting
16. A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum
17. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II
18. Free insulin-like growth factors (IGF-I and IGF-II) in human serum
19. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
20. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats
21. A simple assay for proteolysis of IGFBP-3
22. A review of endocrine changes in anorexia nervosa
23. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats
24. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
25. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease
26. Nutritional status and growth hormone-binding protein
27. Growth hormone-binding proteins and insulin-like growth factor-binding proteins in protein-energy malnutrition, before and after nutritional rehabilitation
28. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women
29. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I and GH-binding protein in postmenopausal women
30. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults
31. Growth hormone (GH) substitution for one year normalises elevated GH-binding protein in GH deficient adults secundary to a reduction in body fat. A placebo-controlled trial
32. Avoiding autocannibalism